跳至主要内容
临床试验/EUCTR2017-002119-33-NL
EUCTR2017-002119-33-NL进行中(未招募)1 期

The PLUS study: Preventing LUmbar Disc Surgery - PLUS study

ZonMW0 个研究点开始时间: 2017年7月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
ZonMW

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • Incapacitating lumbosacral radicular syndrome with leg pain (with or without back pain) that had lasted for a minimum of 6 weeks
  • with or without mild neurological deficit (MRC higher than 3)
  • MRI which confirms a lumbar HNP that compromises the spinal nerve and can explain the clinical symptoms of the patient
  • The patients should according to usual care have an indication for lumbar HNP operation by a neurosurgeon.
  • Signed informed consent for participation in the study
  • 18 years and
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 46

排除标准

  • A potentially eligible subject who meets any of the following criteria will be excluded from participation in this study:
  • Patients exclude suffering from cauda equina syndrome
  • Previous spine surgery at the same level during the previous 6 months
  • Previous transforminal injections at the same level during the previous 6 months
  • Bony stenosis
  • Spondylolisthesis
  • Pregnancy
  • Complicated disc herniation requiring more operations
  • Severe coexisting disease e.g. osteoporosis, dementia
  • Patient with contra-indications for steroids injections
  • Insufficient knowledge of the Dutch language
  • Emergency surgery as determined by the neurosurgeon
  • Severe paresis MRC less than or equal to 3
  • Being allergic for OMNIPAQUE 240

研究者

发起方
ZonMW

相似试验